Literature DB >> 6376027

Sulfonylureas: background and development of the field.

R Levine.   

Abstract

This paper traces the growth of the field from the incidental finding of the hypoglycemic "side effect" of certain antibacterial sulfonamides and sulfonylureas (1942), to the establishment of islet beta cell stimulation and insulin release as a major mechanism of action of these drugs (1946), to the more recent findings that additional effects exist on the level of cell metabolism and its regulation by hormones. These changing concepts of mechanism have influenced the clinical uses of these drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376027

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

Review 1.  Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.

Authors:  Tanya Wilcox; Christophe De Block; Arthur Z Schwartzbard; Jonathan D Newman
Journal:  J Am Coll Cardiol       Date:  2020-04-28       Impact factor: 24.094

2.  Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas.

Authors:  P H Wang; F Beguinot; R J Smith
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

3.  Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?

Authors:  Bo Ahrén
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

4.  Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus.

Authors:  A M Borissova; D G Koev; M G Minev; F G Martinova; P I Gencova; G G Kirilov; J Arnaudov
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

5.  A Brief History of the Development of Diabetes Medications.

Authors:  John R White
Journal:  Diabetes Spectr       Date:  2014-05

6.  History of current non-insulin medications for diabetes mellitus.

Authors:  Celeste C L Quianzon; Issam E Cheikh
Journal:  J Community Hosp Intern Med Perspect       Date:  2012-10-15

7.  Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas.

Authors:  Yousef Al-Saleh; Shaun Sabico; Ahmed Al-Furqani; Amin Jayyousi; Dalal Alromaihi; Ebtesam Ba-Essa; Fatheya Alawadi; Juma Alkaabi; Mohamed Hassanein; Saud Al-Sifri; Seham Saleh; Thamer Alessa; Nasser M Al-Daghri
Journal:  Diabetes Ther       Date:  2021-05-13       Impact factor: 2.945

8.  Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release.

Authors:  Katarzyna Walczewska-Szewc; Wieslaw Nowak
Journal:  J Phys Chem B       Date:  2021-11-26       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.